MOTS-c Wikipedia summary: learn what this mitochondrial peptide does, research on mots-c benefits and dosage, potential side effects, and comparisons.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide that scientists study for its role in metabolism, insulin sensitivity, and the way cells respond to stress. Someone searching for mots c wikipedia is usually looking for a neutral, encyclopedia-style summary rather than a sales page, and that is what this guide aims to provide. There is no detailed standalone Wikipedia article on MOTS-c, so the facts below come from peer-reviewed research published since the peptide was first described in 2015.
What Is MOTS-c?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It was identified in 2015 by a research team at the University of Southern California and described in the journal Cell Metabolism.
Almost every peptide in the body is encoded in nuclear DNA. MOTS-c is different: it is encoded in mitochondrial DNA, the small circular genome inside the mitochondria that power your cells.
Under metabolic stress, MOTS-c travels from the mitochondria into the nucleus, where it helps regulate which genes are switched on. Its best-documented interaction is with AMPK, a master energy sensor that influences how the body burns and stores fuel.
MOTS-c Benefits Reported in Research
Most published evidence for mots-c benefits comes from cell cultures and rodent models. Those results are genuinely interesting, but they are not the same as proven effects in humans, and no regulator has approved the peptide for any human condition.
- Insulin sensitivity. In mouse studies, MOTS-c treatment improved glucose uptake and reduced diet-induced insulin resistance.
- Metabolism. The peptide influences the folate-methionine cycle and purine metabolism, both of which shape how cells manage energy.
- Exercise signaling. MOTS-c levels rise after physical activity, and researchers sometimes call the peptide an "exercise mimetic" because it activates overlapping pathways.
- Aging markers. Observational human data link lower circulating MOTS-c levels with older age and with markers of insulin resistance, though correlation is not causation.
- Antioxidant response. Laboratory work points to a role in the NRF2 stress-defense pathway.
None of this means MOTS-c prevents or treats diabetes, obesity, or aging. It means the biology deserves study, not that a product sold online has proven benefits.
How MOTS-c Compares With AOD-9604, SS-31, and Tesamorelin
Anyone weighing aod 9604 vs mots-c is comparing two very different mechanisms. AOD-9604 is a modified fragment of human growth hormone studied for fat metabolism, while MOTS-c is a mitochondrial peptide studied for glucose handling and cellular energy.
| Compound | Origin | Main research focus | FDA status | Dosing reported in research or community use |
|---|---|---|---|---|
| AOD-9604 | Growth hormone fragment 176-191 | Fat metabolism and lipolysis | Not approved | 300 mcg to 1 mg per day |
| MOTS-c | Mitochondrial 12S rRNA region | Insulin sensitivity, metabolic stress, exercise mimicry | Not approved | 5 to 10 mg, three times per week |
| SS-31 (elamipretide) | Synthetic mitochondria-targeted tetrapeptide | Mitochondrial dysfunction and cardiolipin binding | Investigational, not approved | 5 to 40 mg per day in trials |
| Tesamorelin | GHRH analog | Visceral fat in HIV-associated lipodystrophy | FDA approved (Egrifta) | 1 to 2 mg per day |
The dosing column reflects published research protocols or widely repeated community reports, not approved human doses. Tesamorelin is the only compound in this table with FDA approval, and that approval covers one specific condition.
MOTS-c Dosage: What the Protocols Look Like
There is no established human dose of MOTS-c. Any mots-c dosage chart circulating online is assembled from animal extrapolation and anecdotal reports rather than a completed dose-finding trial.
Ranges that appear most often in research forums and community write-ups include:
- 5 mg injected subcutaneously three times per week
- 10 mg injected subcutaneously once or twice per week
- Total weekly exposure of roughly 10 to 20 mg in higher-end protocols
Vials are typically reconstituted with bacteriostatic water and stored refrigerated, but handling guidance varies by vendor and is not standardized. None of these numbers should be treated as medical advice, and self-dosing an unapproved peptide carries real risk.
MOTS-c Side Effects and Safety
Because no large human trial of injected MOTS-c has been published, most information about mots-c side effects is anecdotal. Reports from users most often mention:
- Injection site redness, swelling, or soreness
- Headache, fatigue, or lightheadedness
- Temporary changes in energy levels or heart rate
- Unclear effects on blood sugar, which matters most for people taking diabetes medication
The bigger unknowns are long-term safety, immune reactions to repeated injections, and purity problems from unregulated suppliers. Anyone considering a research peptide should talk with a licensed healthcare professional first, especially if they take prescription medication or have a metabolic condition.
Stacking and Combination Protocols
A ss-31 and mots-c protocol pairs a mitochondria-targeted antioxidant with a metabolic peptide, and some researchers describe the two as complementary because they act on different parts of mitochondrial function. That reasoning is theoretical; no clinical trial has tested the combination in humans.
Layering MOTS-c with AOD-9604 and tesamorelin is also discussed in peptide communities, usually in the context of fat loss and metabolic support. Each compound works through a different pathway, and mixing them multiplies cost, injection burden, and unknown interactions without evidence of added benefit.
Is MOTS-c Legal to Buy in the United States?
MOTS-c is not an FDA-approved drug, and it is not a dietary supplement. Vendors typically sell it as a research chemical labeled "not for human consumption," which is a legal category that does not involve any review of purity, sterility, or potency.
The FDA has sent warning letters to companies marketing unapproved peptides, and importing them for personal use sits in a gray area. Compounding pharmacies generally cannot dispense MOTS-c without a valid prescription and a documented clinical need.
In short: MOTS-c is a legitimate and active area of scientific research, but it is not a proven therapy, and treating it like one is a gamble rather than a health strategy.
Frequently Asked Questions
Is MOTS-c approved by the FDA?
No. MOTS-c is not FDA-approved for human use and is sold strictly as a research chemical, which means its purity, sterility, and dosing accuracy are not reviewed by the agency. In the comparison group of AOD-9604, SS-31, and tesamorelin, only tesamorelin holds FDA approval, and only for HIV-associated lipodystrophy.
What is a typical MOTS-c dosage?
There is no clinically established human dose of MOTS-c. Community protocols commonly describe 5 to 10 mg injected subcutaneously three times per week, but those figures come from animal extrapolation and anecdotal reports, not controlled trials. Anyone considering the peptide should discuss it with a licensed healthcare professional first.
Does MOTS-c have a Wikipedia page?
MOTS-c does not have a detailed, standalone Wikipedia article the way most prescription drugs do. Information about the peptide tends to appear inside broader entries on mitochondrial-derived peptides, so peer-reviewed journals remain the better source for specifics on mechanism and study results.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.